The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Vaccines and multiple sclerosis: a systematic review
Abstract
Vaccinations are often the most effective tool against some disease known to mankind. This study offers a literature review on the role of vaccines regarding the risk of developing multiple sclerosis (MS) and MS relapse. The method used in this study is a systematic literature review on the database PubMed. The study found no change in risk of developing multiple sclerosis (MS) after vaccination against hepatitis B virus, human papillomavirus, seasonal influenza, measles-mumps-rubella, variola, tetanus, Bacillus Calmette-Guérin (BCG), polio, or diphtheria. No change in risk of relapse was found for influenza. Further research is needed for the potential therapeutic use of the BCG vaccine in patients in risk of developing MS and for the preventive potential of the tetanus and diphtheria vaccine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two recent systematic reviews looking at the association between different individual vaccines and central demyelinating disorders (hepatitis B, human papilloma virus (HPV), influenza, MMR, varicella, tetanus, Bacillus Calmette Guérin (BCG), polio or diphtheria) concluded that there was no relationship between receipt of a vaccine and development of MS (Mailand and Frederiksen, 2017; Mouchet et al”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Mailand and Frederiksen, 2017
In the citing paper
“Existing epidemiologic studies have found no associations between the number of different vaccines and an increased risk of autoimmune disorders.”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Mailand and Frederiksen, 2017
Citations
Cites
Vaccinations and the Risk of Relapse in Multiple Sclerosis
Confavreux, C., Suissa, S., Saddier, P., Bourdès, V., & Vukusic, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440501 · Cited by 490
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
Ascherio, A., Zhang, S. M., Hernán, M. Á., Olek, M. J., COPLAN, P. M., Brodovicz, K. G., & Walker, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440502 · Cited by 433
Recombinant hepatitis B vaccine and the risk of multiple sclerosis
Hernán, M. Á., Jick, S. S., Olek, M. J., & Jick, H. (2004) · Neurology · doi:10.1212/01.wnl.0000138433.61870.82 · Cited by 302
Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
Destefano, F. R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.504 · Cited by 256
Chao, C., Klein, N. P., Velicer, C. M., Sy, L. S., Slezak, J. M., Takhar, H. S., Ackerson, B. K., Cheetham, T. C., Hansen, J. R., Deosaransingh, K. A., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02467.x · Cited by 204
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Langer-Gould, A. M., Qian, L., Tartof, S. Y., Brara, S. M., Jacobsen, S. J., Beaber, B., Sy, L. S., Chao, C., Hechter, R. C., & Tseng, H. F. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2633 · Cited by 190
Bardage, C., Persson, I., Örtqvist, Å., Bergman, U., Ludvigsson, J. F., & Granath, F. (2011) · BMJ · doi:10.1136/bmj.d5956 · Cited by 190
Scheller, N. M., Svanström, H., Pasternak, B., Arnheim‐Dahlström, L., Sundström, K., Fink, K., & Hviid, A. P. (2015) · JAMA · doi:10.1001/jama.2014.16946 · Cited by 182
Use of Bacille Calmette–Guerin (BCG) in multiple sclerosis
Ristori, G., Buzzi, M. G., Sabatini, U., Giugni, E., Bastianello, S., Viselli, F., Buttinelli, C., Ruggieri, S. A., Colonnese, C., Pozzilli, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1588 · Cited by 158
No increase in demyelinating diseases after hepatitis B vaccination
Zipp, F., Weil, J., & Einhäupl, K. M. (1999) · Nature Medicine · doi:10.1038/12376 · Cited by 156
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS
Ristori, G., Romano, S., Cannoni, S., Visconti, A., Tinelli, E., Mendozzi, L., Cecconi, P., Lanzillo, R., Quarantelli, M., Buttinelli, C., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000438216.93319.ab · Cited by 153
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
Mikaeloff, Y., Caridade, G., Suissa, S., & Tardieu, M. (2008) · Neurology · doi:10.1212/01.wnl.0000335762.42177.07 · Cited by 148
Miller, A., Morgante, L., Buchwald, L., Nutile, S., Coyle, P. K., Krupp, L., Doscher, C., LUBLIN, F. D., Knobler, R. L., Trantas, F., et al. (1997) · Neurology · doi:10.1212/wnl.48.2.312 · Cited by 147
School-based hepatitis B vaccination programme and adolescent multiple sclerosis
Sadovnick, A. D., & Scheifele, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(99)02991-8 · Cited by 139
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
Grimaldi‐Bensouda, L., Guillemot, D., Godeau, B., Bénichou, J., Lebrun‐Frénay, C., Papeix, C., Labauge, P. M., Berquin, P. C., Penfornis, A., Benhamou, P., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12155 · Cited by 137
Risk factors of multiple sclerosis: a case-control study
Zorzon, M., Zivadinov, R., Nasuelli, D., Dolfini, P., Bosco, A., Bratina, A., Tommasi, M. A., Locatelli, L., & Cazzato, G. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0147-6 · Cited by 133
A case-control study of serious autoimmune adverse events following hepatitis B immunization
Geier, D. A., & Geier, M. R. (2005) · Autoimmunity · doi:10.1080/08916930500144484 · Cited by 132
Immunizations and risk of multiple sclerosis: systematic review and meta-analysis
Farez, M., & Correale, J. D. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5984-2 · Cited by 132
Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
Keyser, J. D., Zwanikken, C., & Boon, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00139-7 · Cited by 114
Hepatitis B Vaccination and First Central Nervous System Demyelinating Event: A Case-Control Study
Touzé, E., Fourrier, A., Rue-Fenouche, C., Rondé-Oustau, V., Jeantaud, I., Bégaud, B., & Alpérovitch, A. (2002) · Neuroepidemiology · doi:10.1159/000059520 · Cited by 107
Vaccination against infection in patients with multiple sclerosis
Loebermann, M., Winkelmann, A., Hartung, H., Hengel, H., Reisinger, E. C., & Zettl, U. K. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.8 · Cited by 102
Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
Farez, M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.131 · Cited by 101
VIRAL INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS AND HLA-DR MATCHED CONTROLS
Compston, D. A. S., Vakarelis, B. N., Paul, E. A., McDonald, W. I., Batchelor, J. R., & Mims, C. A. (1986) · Brain · doi:10.1093/brain/109.2.325 · Cited by 97
Association of Infectious Mononucleosis with Multiple Sclerosis
Ramagopalan, S. V., Valdar, W. S. J., Dyment, D. A., DeLuca, G. C., Yee, I. M. L., Giovannoni, G., Ebers, G. C., & Sadovnick, A. D. (2009) · Neuroepidemiology · doi:10.1159/000201564 · Cited by 96
Hepatitis B Vaccination and the Risk of Childhood-Onset Multiple Sclerosis
Mikaeloff, Y. (2007) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.161.12.1176 · Cited by 96
INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS*
Sibley, W. A., & Foley, J. M. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20229.x · Cited by 85
Casetta, I., Granieri, E., Malagù, S., Tola, M. R., Paolino, E., Caniatti, L. M., Govoni, V., Monetti, V. C., & Fainardi, E. (1994) · Neuroepidemiology · doi:10.1159/000110369 · Cited by 84
Mikaeloff, Y., Caridade, G., Assi, S., Tardieu, M., Suissa, S., & on behalf of the KIDSEP study group of the French Neuropaediatric Society (2006) · Brain · doi:10.1093/brain/awl368 · Cited by 83
Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France
Berr, C., Puel, J., Clanet, M., Ruidavets, J., Mas, J., & Alpérovitch, A. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03841.x · Cited by 83
Infection Risk in Patients on Multiple Sclerosis Therapeutics
Williamson, E. M. L., & Berger, J. R. (2015) · CNS Drugs · doi:10.1007/s40263-015-0226-2 · Cited by 60
Clinical evaluation of possible etiologic factors in multiple sclerosis
Alter, M., & Speer, J. (1968) · Neurology · doi:10.1212/wnl.18.2.109 · Cited by 60
Moriabadi, N. F., Niewiesk, S., Kruse, N., Jung, S., Weißbrich, B., ter Meulen, V., Toyka, K. V., & Rieckmann, P. (2001) · Neurology · doi:10.1212/wnl.56.7.938 · Cited by 57
Multiple sclerosis in the Faroe Islands
Kurtzke, J. F., Hyllested, K., Arbuckle, J. D., Brønnum‐Hansen, H., Wallin, M. T., Heltberg, A., Jacobsen, H., Olsen, A., & Eriksen, L. S. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00258.x · Cited by 54
Andersen, E., Isager, H., & Hyllested, K. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb00756.x · Cited by 52
Ahlgren, C., Torén, K., Odén, A., & Andersen, O. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9367-2 · Cited by 47
Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations
Ahlgren, C., Odén, A., Torén, K., & Andersen, O. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01131.x · Cited by 45
Hocine, M. N., Farrington, P., Touzé, E., Whitaker, H., Fourrier, A., Moreau, T., & Tubert‐Bitter, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.032 · Cited by 42
Multiple sclerosis in India: a case-control study of environmental exposures
Bansil, S., Singhal, B. S., Gk, A., Riise, T., Ladiwala, U., Behari, M., & Cook, S. D. (1997) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00075.x · Cited by 41
Vaccinations and multiple sclerosis
Gout, O. (2001) · Neurological Sciences · doi:10.1007/s100720170014 · Cited by 39
Salvetti, M., Pisani, A., Bastianello, S., Millefiorini, E., Buttinelli, C., & Pozzilli, C. (1995) · Journal of Neurology · doi:10.1007/bf00936886 · Cited by 39
Merelli, E., & Casoni, F. (2000) · Neurological Sciences · doi:10.1007/s100720070025 · Cited by 38
A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis
Baumhackl, U., Franta, C., Retzl, J., Salomonowitz, E. K., & Eder, G. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00815-0 · Cited by 37
Hepatitis B vaccine and risk of multiple sclerosis
Destefano, F. R., Verstraeten, T., & Chen, R. T. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.4.461 · Cited by 37
Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review
Demicheli, V., Rivetti, A., Pietrantonj, C. D., Clements, C. J., & Jefferson, T. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00423.x · Cited by 36
Risk factors for multiple sclerosis: a case-control study in Israel
Zilber, N., & Kahana, E. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00051.x · Cited by 35
Swine Influenza Vaccination in Patients With Multiple Sclerosis
Bamford, C. R., Sibley, W. A., & Laguna, J. F. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500280060012 · Cited by 34
Influenza Vaccination in Patients With Multiple Sclerosis
Sibley, W. A. (1976) · JAMA · doi:10.1001/jama.1976.03270180041018 · Cited by 34
McNicholas, N., & Chataway, J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5944-x · Cited by 33
Swine Influenza Virus Vaccination in Patients with Multiple Sclerosis
Myers, L. W., Ellison, G. W., Lucia, M., NOVOM, S., Mi, H., Madden, D. L., Sever, J. L., & Noble, G. R. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement_3.s546 · Cited by 30
Influenza virus vaccination of patients with multiple sclerosis
Mokhtarian, F., Shirazian, D., Morgante, L., Miller, A., Grob, D., & Lichstein, E. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300405 · Cited by 29
Mass Vaccination Against Hepatitis B: The French Example
Denis, F., & Lévy-Bruhl, D. (2006) · Springer eBooks · doi:10.1007/3-540-36583-4_7 · Cited by 26
Multiple sclerosis and immunological-related risk factors: Results from a case-control study
Eftekharian, M. M., Mousavi, M., Hormoz, M. B., Roshanaei, G., & Mazdeh, M. (2015) · Human Antibodies · doi:10.3233/hab-150281 · Cited by 25
Farez, M., Ysrraelit, M. C., Fiol, M. P., & Correale, J. D. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511417253 · Cited by 25
Seasonal and H1N1v influenza vaccines in MS: Safety and compliance
Auriel, E., Gadoth, A., Regev, K., & Karni, A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.013 · Cited by 24
Childhood Infections as Risk Factors for Multiple Sclerosis: Belgrade Case-Control Study
Pekmezovic, T. D., Jarebinski, M., & Drulovic, J. S. (2004) · Neuroepidemiology · doi:10.1159/000080094 · Cited by 22
Demyelinating Disease and Hepatitis B Vaccination
Jefferson, T., & Heijbel, H. (2001) · Drug Safety · doi:10.2165/00002018-200124040-00002 · Cited by 19
Michielsens, B., Wilms, G. E., Marchal, G., & Carton, H. (2008) · European Neurology · doi:10.1159/000117358 · Cited by 18
Vaccination of patients with Encephalomyelitis disseminata
Quast, U., Herder, C., & Zwisler, O. (1991) · Vaccine · doi:10.1016/0264-410x(91)90104-e · Cited by 18
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus
Pellegrino, P., Carnovale, C., Perrone, V., Antoniazzi, S., Pozzi, M., Clementi, E., & Radice, S. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9830-y · Cited by 17
Pool, V. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1519 · Cited by 14
Özakbaş, S., İdıman, E., Yuluğ, B., Paköz, Z. B., Bahar, H., & Gülay, Z. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00653.x · Cited by 9
Relationship between Vaccinations and Multiple Sclerosis
Sievers, E. J., & Heyneman, C. A. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph10420 · Cited by 6
Relationship Between Vaccinations and Multiple Sclerosis
Sievers, E. J., & Heyneman, C. A. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a096 · Cited by 5
Cited by
Sorted by citations
Vaccine Safety: Myths and Misinformation
Geoghegan, S., O’Callaghan, K. P., & Offit, P. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00372 · Cited by 275
“A metanalysis of 39 controlled observational studies found that the relative risk of GBS following receipt of any influenza vaccine was 1.41 (Martin Arias et al., 2015).”
InfluentialCOVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
Achiron, A., Dolev, M., Menascu, S., Zohar, D. N., Dreyer-Alster, S., Miron, S., Shirbint, E., Magalashvili, D., Flechter, S., Givon, U., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211003476 · Cited by 212
Ocular Adverse Events After COVID-19 Vaccination
Ng, X. L., Betzler, B. K., Testi, I., Ho, S. L., Tien, M. C.-H., Ngo, W. K., Zierhut, M., Chee, S.-P., Gupta, V., Pavesio, C. E., et al. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2021.1976221 · Cited by 187
Wagner, N., Assmus, F., Arendt, G., Baum, E., Baumann, U., Bogdan, C., Burchard, G. D., Föll, D., Garbe, E., Hecht, J., et al. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-02905-1 · Cited by 150
Effects of MS disease-modifying therapies on responses to vaccinations: A review.
Ciotti, J. R., Valtcheva, M. V., & Cross, A. H. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102439 · Cited by 135
Metadata
- Authors
- Mailand, M. T., & Frederiksen, J. L.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Frederiksen, Jette Lautrup
- Venue
- Journal of Neurology
- Published
- 2016-09-07
- Volume
- 264
- Issue
- 6
- Pages
- 1035-1050
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2514636267
- Cited by
- 154
- References
- 63
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 14 · 2023: 23 · 2022: 20 · 2021: 32 · 2020: 22 · 2019: 12 · 2018: 14 · 2017: 6 · 2016: 1
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- multiple sclerosis, vaccines, hepatitis B vaccine, HPV vaccine, seasonal influenza vaccine, MMR vaccine, smallpox vaccine, tetanus vaccine, BCG vaccine, diphtheria vaccine, polio vaccine, multiple sclerosis risk, relapse
- MeSH terms
- Animals, Humans, Multiple Sclerosis, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
